McNeil Consumer Healthcare is an American medical products company that primarily markets fast-moving consumer healthcare goods, including well-known over-the-counter medications like Tylenol and Motrin IB. It is a subsidiary of Kenvue, the consumer health group spun off from Johnson & Johnson. The company was originally founded in 1879 and has a long history in pharmaceuticals and consumer healthcare products. McNeil focuses on both over-the-counter and some prescription products, operating mainly from its headquarters in Fort Washington, Pennsylvania, with a workforce of around 2,600 people. In recent news, McNeil Consumer Healthcare is involved in a controversy where the White House, under the current administration, has linked the use of acetaminophen (Tylenol) during pregnancy to autism, leading to potential major lawsuits and impacting the stock value of Kenvue. McNeil and Kenvue strongly dispute these claims, citing scientific evidence to the contrary. McNeil's product portfolio includes popular consumer brands such as Tylenol, Motrin IB, Lactaid (for lactose intolerance), and others. The company has gone through various ownership and name changes, with significant mergers and acquisitions, but remains a major player in consumer healthcare products in the US and internationally.
Key Points About McNeil Consumer Healthcare
- Founded in 1879, part of the Kenvue consumer health group.
- Manufactures over-the-counter medicines like Tylenol and Motrin IB.
- Headquarters in Fort Washington, Pennsylvania, with about 2,600 employees.
- Recently faced controversy regarding Tylenol use in pregnancy linked to autism.
- Also markets Lactaid and other consumer health brands.
- Was formerly part of Johnson & Johnson before Kenvue spin-off.
- Has a history of product recalls and regulatory scrutiny but remains a significant healthcare brand.
This summary provides insight into McNeil Consumer Healthcare's identity, products, recent challenges, and corporate background.
